Papillary Thyroid Cancer Market Growth and Segments,2016-2026 FMI | Page 3

Report
Description
Report Description
Papillary thyroid cancer (PTC) also called papillary carcinoma is one of the most common
type of thyroid cancer and it is most curable among other cancers. Follicular cancer,
medullary cancer, and anaplastic cancer are other types of thyroid cancers. The
prevalence rate of papillary thyroid cancer is 0.5-10 per 100,000 population. Papillary
thyroid carcinoma presents as asymptomatic thyroid nodules, increasing the size of
nodule in patient is the primary symptom for this disease. Cough, dyspnea and dysphagia
are the severe stage symptoms of papillary thyroid cancer and lump or swelling in the
neck parts are the physical symptoms of the papillary thyroid cancer. Age, gender and
exposure to radiation affect the risk of papillary thyroid cancer. Itis more common in
women than in men, and often occurs before age 45. People who have been exposed to
large amounts of radiation, or who have had radiation therapy for medical problems in
the head and neck have a more chance of getting thyroid cancer.
To treat papillary thyroid cancer various methods are available which include surgical
procedure, iodine therapy, thyroxin treatment and external radiotherapy. In surgical
procedure, surgeon removes affected tissue from the neck. Iodine therapy is given to the
patient post operatively to destroy normal thyroid remnants. External radiotherapy is
indicated for the patients with age group 45 years and above.
Request for sample report: http://www.futuremarketinsights.com/reports/sample/repgb-1659
The growth of thyroid tumor cells are controlled by thyrotropin and is inhibited by
thyroxin, inhibition of thyrotropin with thyroxin increase the recurrence of survival rates.